Join the Chronic Migraine group to help and get support from people like you.
Chronic Migraine News (Page 2)
Related terms: Migraine, Chronic
Atogepant Superior for Efficacy, Functional Measures in Migraine
THURSDAY, Dec. 26, 2024 – For adults with migraine, atogepant 60 mg once daily was superior to placebo for efficacy and functional measures of treatment across three trials, according to research...
Clinical Practice Guideline Updated for Migraine, Tension-Type Headache
TUESDAY, Oct. 29, 2024 – In a clinical practice guideline (CPG) issued by the U.S. Department of Veterans Affairs and U.S. Department of Defense and published online Oct. 29 in the Annals of...
Study Addresses Differentiating Meniere Disease, Vestibular Migraine
THURSDAY, Oct. 3, 2024 – The dissociation between pathological caloric testing and a normal video head impulse test can differentiate between Meniere disease (MD) and vestibular migraine (VM),...
Review Compares Drug Interventions for Acute Migraine Treatment
MONDAY, Sept. 23, 2024 – All active interventions show superior efficacy to placebo for freedom from pain, and most do for sustained pain freedom, for the acute treatment of migraine among adults,...
Erenumab Effective for Nonopioid Medication Overuse Headache in Chronic Migraine
WEDNESDAY, Sept. 18, 2024 – Monthly use of erenumab injections (140 mg) is safe and effective in achieving medication overuse headache (MOH) remission in patients with nonopioid chronic migraine...
Monoclonal Antibody Tops Placebo for Reducing Migraine Frequency
WEDNESDAY, Sept. 4, 2024 – The humanized monoclonal antibody directed against the pituitary adenylate cyclase-activating polypeptide (PACAP) ligand, Lu AG09222, is better than placebo for reducing...
Migraine Drug Ubrelvy May Stop Headaches Before They Start
THURSDAY, Aug. 29, 2024 – A migraine drug can help stop the devastating headaches in their tracks, allowing sufferers to go about their daily lives with little to no symptoms, a new clinical trial...
Ubrogepant Administered During Prodrome Beneficial for Migraine
WEDNESDAY, Aug. 28, 2024 – For adults experiencing migraine attacks with moderate-to-severe headache pain, ubrogepant administered during prodrome is beneficial for patient-reported outcomes,...
No Link Found Between Migraines, Parkinson's Disease
FRIDAY, Aug. 23, 2024 – Women who suffer frequent migraines don’t have any increased risk of developing Parkinson’s disease, finds a new study that refutes earlier research. “These results are reass...
Migraine in Women Not Linked to Risk for Parkinson Disease
THURSDAY, Aug. 22, 2024 – Migraine is not associated with an increased risk for developing Parkinson disease (PD) among women, according to a study published online Aug. 21 in Neurology. Ricarda S....
Most Traditional Cardiovascular Risk Factors Not Linked to Migraine
WEDNESDAY, July 31, 2024 – For women, many traditional cardiovascular risk factors (CVRFs) are inversely associated with migraine risk, according to a study published online July 31 in Neurology....
High Blood Pressure Might Help Spur Migraines
THURSDAY, Aug. 1, 2024 – High blood pressure might increase a woman’s odds of suffering migraines, a new study finds. Specifically, high diastolic blood pressure is linked to a slightly higher risk o...
Direct CGRP Inhibition Cuts Acne, Rosacea in Patients With Migraine
TUESDAY, July 16, 2024 – For patients experiencing migraine, direct calcitonin gene-related peptide (CGRP) inhibition with monoclonal antibodies (mAbs) is associated with reduced rates of acne and...
Atogepant Efficacious for Patients With Chronic Migraine
WEDNESDAY, June 26, 2024 – For patients with chronic migraine (CM), with and without medication overuse, atogepant is efficacious, according to a study published online June 27 in Neurology. Peter...
Migraine Prevention Med Quilipta Might Stop 'Rebound' Headaches, Too
THURSDAY, June 27, 2024 – It's a nasty cycle: Chronic migraine sufferers who use too much pain medication sometimes get smacked with rebound headaches. But new research suggests that a medication...